Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Expert Analyses of the following article:

New Treatment Halts Progress of Alzheimer's Disease

Source: www.abdn.ac.uk
August 6, 2008
Concerns about the Rember Phase 2 data
Author: GLG Expert Contributor
While the clinical trial data remain unpublished, those who attended the ICAD conference remain concerned about the possibility that the effects are not as pronounced as the interpretation by the investigators.
August 5, 2008
Biostatistical and Experimental Design Assessment of Research on Tau Tangle Targeting for Alzheimer’s Disease
Author: William Shannon, PhD, Founder and President, BioRankings, LLC
Slowing the progression of Alzheimer's disease by attacking tau tangles is a novel idea that should be considered a viable treatment alternative, especially in light of the failings of some recent beta-amyloid treatment strategies (e.g., Flurizan).   At the 2008 International Conference on Alzheimer's Disease (ICAD 2008), Dr. Claude Wischik (Univ. of Aberdeen and TauRx Pharmaceuticals) and...

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-10-10T21:45:17.060